Cargando…

Single-cell heterogeneity and dynamic evolution of Ph-like acute lymphoblastic leukemia patient with novel TPR-PDGFRB fusion gene

Philadelphia chromosome-like acute lymphoblastic leukemia (Ph-like ALL) is a refractory and recurrent subtype of B-cell ALL enriched with kinase-activating rearrangements. Incomplete understanding of the heterogeneity within the tumor cells presents a major challenge for the diagnosis and therapy of...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xuehong, Hou, Zhijie, Huang, Dan, Wang, Furong, Gao, Beibei, Zhang, Chengtao, Zhou, Dong, Lou, Jiacheng, Wang, Haina, Gao, Yuan, Kang, Zhijie, Lu, Ying, Liu, Quentin, Yan, Jinsong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9936632/
https://www.ncbi.nlm.nih.gov/pubmed/36797781
http://dx.doi.org/10.1186/s40164-023-00380-8
_version_ 1784890270758731776
author Zhang, Xuehong
Hou, Zhijie
Huang, Dan
Wang, Furong
Gao, Beibei
Zhang, Chengtao
Zhou, Dong
Lou, Jiacheng
Wang, Haina
Gao, Yuan
Kang, Zhijie
Lu, Ying
Liu, Quentin
Yan, Jinsong
author_facet Zhang, Xuehong
Hou, Zhijie
Huang, Dan
Wang, Furong
Gao, Beibei
Zhang, Chengtao
Zhou, Dong
Lou, Jiacheng
Wang, Haina
Gao, Yuan
Kang, Zhijie
Lu, Ying
Liu, Quentin
Yan, Jinsong
author_sort Zhang, Xuehong
collection PubMed
description Philadelphia chromosome-like acute lymphoblastic leukemia (Ph-like ALL) is a refractory and recurrent subtype of B-cell ALL enriched with kinase-activating rearrangements. Incomplete understanding of the heterogeneity within the tumor cells presents a major challenge for the diagnosis and therapy of Ph-like ALL. Here, we exhibited a comprehensive cell atlas of one Ph-like ALL patient with a novel TPR-PDGFRB fusion gene at diagnosis and relapse by using single-cell RNA sequencing (scRNA-seq). Twelve heterogeneous B-cell clusters, four with strong MKI67 expression indicating highly proliferating B cells, were identified. A relapse-enriched B-cell subset associated with poor prognosis was discovered, implicating the transcriptomic evolution during disease progression. Integrative single-cell analysis was performed on Ph-like ALL and Ph(+) ALL patients, and revealed Ph-like specific B-cell subpopulations and shared malignant B cells characterized by the ectopic expression of the inhibitory receptor CLEC2D. Collectively, scRNA-seq of Ph-like ALL with a novel TPR-PDGFRB fusion gene provides valuable insights into the underlying heterogeneity associated with disease progression and offers useful information for the development of immunotherapeutic techniques in the future. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40164-023-00380-8.
format Online
Article
Text
id pubmed-9936632
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-99366322023-02-18 Single-cell heterogeneity and dynamic evolution of Ph-like acute lymphoblastic leukemia patient with novel TPR-PDGFRB fusion gene Zhang, Xuehong Hou, Zhijie Huang, Dan Wang, Furong Gao, Beibei Zhang, Chengtao Zhou, Dong Lou, Jiacheng Wang, Haina Gao, Yuan Kang, Zhijie Lu, Ying Liu, Quentin Yan, Jinsong Exp Hematol Oncol Correspondence Philadelphia chromosome-like acute lymphoblastic leukemia (Ph-like ALL) is a refractory and recurrent subtype of B-cell ALL enriched with kinase-activating rearrangements. Incomplete understanding of the heterogeneity within the tumor cells presents a major challenge for the diagnosis and therapy of Ph-like ALL. Here, we exhibited a comprehensive cell atlas of one Ph-like ALL patient with a novel TPR-PDGFRB fusion gene at diagnosis and relapse by using single-cell RNA sequencing (scRNA-seq). Twelve heterogeneous B-cell clusters, four with strong MKI67 expression indicating highly proliferating B cells, were identified. A relapse-enriched B-cell subset associated with poor prognosis was discovered, implicating the transcriptomic evolution during disease progression. Integrative single-cell analysis was performed on Ph-like ALL and Ph(+) ALL patients, and revealed Ph-like specific B-cell subpopulations and shared malignant B cells characterized by the ectopic expression of the inhibitory receptor CLEC2D. Collectively, scRNA-seq of Ph-like ALL with a novel TPR-PDGFRB fusion gene provides valuable insights into the underlying heterogeneity associated with disease progression and offers useful information for the development of immunotherapeutic techniques in the future. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40164-023-00380-8. BioMed Central 2023-02-17 /pmc/articles/PMC9936632/ /pubmed/36797781 http://dx.doi.org/10.1186/s40164-023-00380-8 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Correspondence
Zhang, Xuehong
Hou, Zhijie
Huang, Dan
Wang, Furong
Gao, Beibei
Zhang, Chengtao
Zhou, Dong
Lou, Jiacheng
Wang, Haina
Gao, Yuan
Kang, Zhijie
Lu, Ying
Liu, Quentin
Yan, Jinsong
Single-cell heterogeneity and dynamic evolution of Ph-like acute lymphoblastic leukemia patient with novel TPR-PDGFRB fusion gene
title Single-cell heterogeneity and dynamic evolution of Ph-like acute lymphoblastic leukemia patient with novel TPR-PDGFRB fusion gene
title_full Single-cell heterogeneity and dynamic evolution of Ph-like acute lymphoblastic leukemia patient with novel TPR-PDGFRB fusion gene
title_fullStr Single-cell heterogeneity and dynamic evolution of Ph-like acute lymphoblastic leukemia patient with novel TPR-PDGFRB fusion gene
title_full_unstemmed Single-cell heterogeneity and dynamic evolution of Ph-like acute lymphoblastic leukemia patient with novel TPR-PDGFRB fusion gene
title_short Single-cell heterogeneity and dynamic evolution of Ph-like acute lymphoblastic leukemia patient with novel TPR-PDGFRB fusion gene
title_sort single-cell heterogeneity and dynamic evolution of ph-like acute lymphoblastic leukemia patient with novel tpr-pdgfrb fusion gene
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9936632/
https://www.ncbi.nlm.nih.gov/pubmed/36797781
http://dx.doi.org/10.1186/s40164-023-00380-8
work_keys_str_mv AT zhangxuehong singlecellheterogeneityanddynamicevolutionofphlikeacutelymphoblasticleukemiapatientwithnoveltprpdgfrbfusiongene
AT houzhijie singlecellheterogeneityanddynamicevolutionofphlikeacutelymphoblasticleukemiapatientwithnoveltprpdgfrbfusiongene
AT huangdan singlecellheterogeneityanddynamicevolutionofphlikeacutelymphoblasticleukemiapatientwithnoveltprpdgfrbfusiongene
AT wangfurong singlecellheterogeneityanddynamicevolutionofphlikeacutelymphoblasticleukemiapatientwithnoveltprpdgfrbfusiongene
AT gaobeibei singlecellheterogeneityanddynamicevolutionofphlikeacutelymphoblasticleukemiapatientwithnoveltprpdgfrbfusiongene
AT zhangchengtao singlecellheterogeneityanddynamicevolutionofphlikeacutelymphoblasticleukemiapatientwithnoveltprpdgfrbfusiongene
AT zhoudong singlecellheterogeneityanddynamicevolutionofphlikeacutelymphoblasticleukemiapatientwithnoveltprpdgfrbfusiongene
AT loujiacheng singlecellheterogeneityanddynamicevolutionofphlikeacutelymphoblasticleukemiapatientwithnoveltprpdgfrbfusiongene
AT wanghaina singlecellheterogeneityanddynamicevolutionofphlikeacutelymphoblasticleukemiapatientwithnoveltprpdgfrbfusiongene
AT gaoyuan singlecellheterogeneityanddynamicevolutionofphlikeacutelymphoblasticleukemiapatientwithnoveltprpdgfrbfusiongene
AT kangzhijie singlecellheterogeneityanddynamicevolutionofphlikeacutelymphoblasticleukemiapatientwithnoveltprpdgfrbfusiongene
AT luying singlecellheterogeneityanddynamicevolutionofphlikeacutelymphoblasticleukemiapatientwithnoveltprpdgfrbfusiongene
AT liuquentin singlecellheterogeneityanddynamicevolutionofphlikeacutelymphoblasticleukemiapatientwithnoveltprpdgfrbfusiongene
AT yanjinsong singlecellheterogeneityanddynamicevolutionofphlikeacutelymphoblasticleukemiapatientwithnoveltprpdgfrbfusiongene